Stephen L. Huhn

Insider Reports History

Location
San Diego, CA
Signature
/s/ Peter Slover, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen L. Huhn:

Company Role Class Num Shares Value Price $ Report Date Ownership
Contineum Therapeutics, Inc. CMO & Sr VP, Clinical Dev. Class A Common Stock 12,800 $218,240 $17.05 13 Aug 2024 Direct
Contineum Therapeutics, Inc. CMO & Sr VP, Clinical Dev. Stock Option (right to buy) 110,000 31 Jan 2025 Direct

Insider Reports Filed by Stephen L. Huhn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CTNM Contineum Therapeutics, Inc. 31 Jan 2025 1 $0 4 CMO & Sr VP, Clinical Dev. 31 Jan 2025, 16:38
CTNM Contineum Therapeutics, Inc. 13 Aug 2024 2 +$12,928 4 CMO & Sr VP, Clinical Dev. 14 Aug 2024, 18:03
CTNM Contineum Therapeutics, Inc. 24 May 2024 1 $0 4 CMO & Sr VP, Clinical Dev. 29 May 2024, 17:56
CTNM Contineum Therapeutics, Inc. 04 Apr 2024 0 $0 3 CMO & Sr VP, Clinical Dev. 04 Apr 2024, 17:54